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Introduction {#sec1}
============

The human gut is colonized by a dense microbial community, calculated to consist of 10^14^ cells, which is an order of magnitude higher than the number of cells in the host ([@bib27]). This gut microbiota is a complex ecosystem that carries multiple important functions in the organism such as digestion, immunity, and vitamin and other important metabolite production and even affects higher neural functions ([@bib1]). The interaction, however, is not one-sided: microbiota is not simply determining certain host characteristics, as it also responds to signals from the host via multiple feedback loops ([@bib15]).

The totality of processes gut microflora participates in cannot be dismissed as irrelevant. Detecting and interpreting the host-microbe interactions is essential to gain more control over host health status. Although host-microbe dialogue can be relatively easily detected with modern biological technology, its interpretation poses a much more challenging task. High-throughput methods allow to observe changes in microflora composition between host cohorts, but it is not always evident which of them are pathological and which represent transition between alternative healthy states. In this article we aspire to provide a tool that would let researchers account for normal changes associated with healthy aging.

Just as its host, human microflora matures and ages with years. This starts in infancy with gut colonization. Factors such as mode of delivery and diet (formula or breast milk) greatly affect the track along which pioneer microbiota progresses ([@bib31]). But their effects are well documented and there are multiple studies that show consistent succession in the infant gut community ([@bib13]).

Microflora evolution does not stop in childhood but extends into adulthood and old age. However, adult hosts exhibit significantly more variable phenotypes and conditions that drive community dynamics. This variability obscures the view of microflora succession and leads to confusion and contradictory results---stark contrast with the case of infant microflora. For example, some studies report a general decrease in biodiversity as an indicator of old age, whereas other studies show that the healthy elderly may have microflora as diverse as that of the younger population ([@bib7], [@bib19]).

Regardless of these complications, establishing regularities of intestinal succession in adults is of utmost importance, since deciphering them means grasping control over certain aspects of organismal aging. This potential application of microflora studies has long entertained the minds of biogerontologists, but only recently the technology has allowed to see its outlines. Historically, the first theory of intestinal aging was developed by a Nobel Prize-winning Russian scientist Ilya Metchnikoff in the beginning of the 20^th^ century ([@bib4]). He proposed that malicious microbes processing undigested food, especially peptolytic bacteria, e.g., *Escherichia* and *Clostridium*, promote autointoxication. Treating autointoxication with pro- and pre-biotics, such as *Lactobacillus* preparations, was suggested as a way of alleviating the age-associated decline in organismal function. Recent studies have demonstrated promising results in line with this century-old hypothesis ([@bib12]).

Yet such findings are disorganized and need to be unified into a theory of gut community dynamics. One of the stepping stones to this theory would be a reliable way to measure the passage of time in gut community and the ability to tell two temporally different states apart---the very foundation of any dynamics theory. In this context, DNAm aging clocks provide an image of the solution. In essence, DNAm clocks illustrate that machine learning techniques can be used to define a new time dimension, which unlike chronological time, very conveniently can flow in both directions. This substitute time can be manipulated and used to tell apart biological systems that have been unequally affected by aging, even if they have the same chronological age. The success of this concept has inspired many other research groups to seek and interpret molecular footprints of aging in molecular-level features.

However, this quest has produced only limited results in the gut metagenomics field, despite there being a mass of reports on specific microbes\' involvement with aging. The complexity of microbiome and its susceptibility to multiple variables apart from age complicate the basic task of aggregating the available information into an intestinal aging clock. Some researchers avoid cross-study designs, which on the one hand remove the batch effect problem, but on the other greatly reduce the power of resulting models. For example, a support vector machine model trained on human metagenomic data of 52 samples to classify samples as either young or old was shown to be only 10%--15% more accurate than the random assignment, as indicated by the area under the curve score ([@bib14]). Another study, which attempted to use a co-abundance clustering approach, demonstrated general trendlines of microbiota composition for 367 individuals aged 0--100 years ([@bib21]). According to the study, specific clades of the gut community differ significantly in abundance between different age groups. But despite the greater sample size the authors still render it impossible to put together a quantitative theory of intestinal aging, at least without controlling other important variables, such as diet.

In this study, we aim to deliver an accurate aging clock based on gut metagenomics. For this, we aggregated more than 4,000 metagenomic profiles from people aged 18--90 years. Moreover, we have used Deep Neural Network (DNN) as our model of choice. Its flexibility and ability to solve non-linear cases have made DNNs extremely useful in image, text, and voice recognition as well as in a number of biomedical applications ([@bib2]). Most recently, DNNs have permeated biogerontology, allowing the construction of aging clocks of superior quality using various data types: standard clinical blood tests ([@bib16]), facial images ([@bib8]), physical activity ([@bib23]), and transcriptomic data ([@bib17]). As such, DNNs emerge as an optimal method to decipher the links between aging and microflora composition.

Combining an extensive cross-study data approach with DNN training, we managed to construct a clock that shows 5.91 years mean absolute error (MAE) when tested on an independent set of ∼400 taxonomic profiles from healthy individuals. This accuracy is comparable with the existing DNAm solutions, which typically reach MAE \<5 years. We further describe how the most abundant microbes (in terms of relative abundance) affect age prediction, which has let us identify understudied, yet important, species as potential biomarkers of intestinal aging.

Results {#sec2}
=======

Age Prediction Using Machine Learning {#sec2.1}
-------------------------------------

To examine the relationship between human gut taxonomic profiles and chronological age, we prepared a collection of full metagenome sequences for 1,165 healthy individuals (3,663 samples total) from 10 publicly available datasets. All individuals in our dataset were between 20 and 90 years old, with median age of 46 years ([Figure S1](#mmc1){ref-type="supplementary-material"}). We applied four machine learning (ML) algorithms: Elastic Net (EN), Random Forest (RF), Gradient Boosting (XGB), and DNN, to this dataset. All samples obtained from the same donor were collapsed into one averaged profile (1,165 profiles from 3,663 samples).

Both in cross-validation (CV) and independent verification DNNs produced the most accurate models ([Table 1](#tbl1){ref-type="table"}): 10.60 years MAE with baseline being 13.75 years ([Tables S1](#mmc2){ref-type="supplementary-material"}). EN failed to predict better than median age assignment in both sample-based and host-based settings. Interestingly, DNNs also produce the most consistent models among folds, as indicated by the least standard deviations in MAE.Table 1Performance of the DNN Model on Independent Testing Sets with Healthy Individuals (HC) or Subjects with Type 1 Diabetes (T1D) and on Cross-Validation (CV) TestCV HostIndependent HCIndependent T1DNeural networksR^2^0.21 ± 0.130.29 ± 0.09−0.98 ± 0.17MAE, years![](fx2.gif)![](fx3.gif)![](fx4.gif)r0.52 ± 0.110.53 ± 0.050.14 ± 0.08Baseline MAE, years13.039.2713.65Median age, years504933.5N, profiles1,16540234Machine learningElastic Net MAE, years![](fx5.gif)![](fx6.gif)![](fx7.gif)Random Forest MAE, years11.32 ± 4.187.06 ± 0.49![](fx8.gif)XGBoost MAE, years11.06 ± 3.917.11 ± 0.54![](fx9.gif)[^2][^3]

We then divided the samples into three age groups (20--39, 40--59, and 60--90 years) and found that the predicted age distribution generated by our DNN was significantly skewed toward the dataset median age (50 years) ([Figure 1](#fig1){ref-type="fig"}).Figure 1Predicted and Actual Age Density Distributions for Profiles Used during CVDespite predictions being skewed toward median age (50 years), the predictor performs better than median age assignment (MAE = 13.75 years). "N" stands for the total number of samples per class. Dashed lines within violins stand for quartile borders. See [Figure S1, S8](#mmc1){ref-type="supplementary-material"} and [Table S6](#mmc1){ref-type="supplementary-material"} for original data structure.

Independent Dataset Validation {#sec2.2}
------------------------------

To validate our aging models we have prepared a set of 436 metagenomic runs (18--70 years old) from three additional independent studies ([PRJEB2054](https://www.ebi.ac.uk/ena/data/view/PRJEB2054){#intref0010}, [PRJNA375935](https://www.ebi.ac.uk/ena/data/view/PRJNA375935){#intref0015}, [PRJNA289586](https://www.ebi.ac.uk/ena/data/view/PRJNA289586){#intref0020}), one of which had 34 runs obtained from donors with type 1 diabetes (T1D) ([PRJNA289586](https://www.ebi.ac.uk/ena/data/view/PRJNA289586){#intref0025}). Only the best models from each ML algorithm, as established in CV, were validated in this setting. As in CV, EN failed to produce better than baseline predictions. All other ML techniques produced results with MAE in the 7- to 8-year range with the exception of DNN, which predicted healthy donors with 5.91 years of MAE, compared with 9.27 years of MAE for median age assignment ([Figure 2](#fig2){ref-type="fig"}). Although most models outperformed baselines in healthy donors, they failed to achieve that with samples from diabetic people. Since some profiles in the verification set belong to the same donor (435 profiles for 271 donor), we also report that using MAE for averaged per donor predictions is 6.85 years for healthy people and 18.03 for diabetic people.Figure 2Microbiome Clock Predictions in CV (Top) and Independent Validation (Bottom)Solid lines indicate linear fits for predictions derived from healthy individuals\' (HC) samples: R2CV, Host = 0.64. Dash-dotted lines indicate linear fits for predictions derived from samples of people with type 1 diabetes (T1D). More metrics are available in [Table 1](#tbl1){ref-type="table"}. "N" stands for the number of metagenomic profiles used in either CV or verification stages. Note: independent verification panels have one outlier sample omitted (SRR6474267, actual age: 37 years, age predicted by the microbiome aging clock: 93 years). See [Table S1](#mmc2){ref-type="supplementary-material"} for individual predictions and [Figure S9](#mmc1){ref-type="supplementary-material"} for prediction plots of an alternative model.

Unlike in CV, predictions obtained from individual folds are much more consistent for all models, which can indicate reduced data heterogeneity due to using only three studies instead of ten.

Interpreting DNN Clock Features {#sec2.3}
-------------------------------

We applied the accumulated local effect (ALE) method (see [Methods](#sec4){ref-type="sec"}, [Figure S2](#mmc1){ref-type="supplementary-material"}) to the validation set to compare how the DNN model treats its 100 most prevalent features ([Figures 3](#fig3){ref-type="fig"} and [S2](#mmc1){ref-type="supplementary-material"}). The overall contribution of any single microbe is less than 2 years in both models with most microbes being able to shift the prediction age by less than 0.5 years ([Table S5](#mmc1){ref-type="supplementary-material"}).Figure 3Accumulated Local Effect (ALE) Plots for Four Selected Microbial Taxa Derived from Perturbing Taxonomic Profiles in CV DatasetALE plots display how changes in a specific microbe\'s relative abundance (over a span of population-specific values) shift the model predictions toward acceleration or regression of age (in years); e.g., people with the abundance of *Veillonella parvula* higher than 95% of the population are predicted to be 0.25--0.3 years younger than those who have very little of this bacterium. See [Figure S2](#mmc1){ref-type="supplementary-material"} for ALE explanation, [Figure S3](#mmc1){ref-type="supplementary-material"} for an aggregated plot of more species, and [Figure S10](#mmc1){ref-type="supplementary-material"} for comparison with an alternative DNN model. Specific ALE values can be found in [Tables S4](#mmc5){ref-type="supplementary-material"} and [S5](#mmc6){ref-type="supplementary-material"}.

Closer inspection shows that the microbes with greater influence ([Figure 4](#fig4){ref-type="fig"}) largely consist of well-studied participants of the gut community that may carry both beneficial (e.g., *Bifidobacterium spp*., *Akkermansia muciniphila*, *Bacteroides spp*.) and negative (e.g., *Escherichia coli*, *Campylobacter jejuni*) traits. Some bacteria in the list, however, are rarely described in the context of human gut community (e.g., *Streptococcus equinus*, *Chryseobacterium gallinarum*, *Ornithobacterium rhinotracheale*).Figure 4Microbial Species Ordered by the Shift in the Predicted Age They Can Cause in the DNN ModelMicrobes whose increased relative abundance causes either a generally positive or negative shift are called seno-positive or seno-negative, respectively. Microbes that do not have a monotone effect on age prediction are called mixed. Only microbes whose effect amplitude is \> 0.1 years are displayed (see [Tables S4](#mmc5){ref-type="supplementary-material"} and [S5](#mmc6){ref-type="supplementary-material"} and [Figure S2](#mmc1){ref-type="supplementary-material"}).

Interestingly, within the tested dataset most microbes weakly affect the predictor until their relative abundance reaches a certain population-specific threshold. Exploring ALEs in a similar fashion for the training set of the host-based clock, we find that the steepest shifts in prediction also occur at the right end of microbe\'s abundance distribution ([Tables S4](#mmc5){ref-type="supplementary-material"} and [S5](#mmc6){ref-type="supplementary-material"}).

Discussion {#sec3}
==========

This study describes a proof of concept aging clock based on microbiomic data. Among other ML algorithms, such as EN, RF, and XGB, DNN was shown to produce the best performing age predictors. A DNN trained on WGS microbiome data achieved an MAE of 10.60 years in CV and 5.91 during independent verification, which is significantly better than the baseline (median age assignment) ([Table 1](#tbl1){ref-type="table"}). Meanwhile, EN was shown to be unfit for the task of intestinal age prediction, since this ML method failed to produce better than baseline models in any setting we tested.

Interestingly, all models assigned a higher predicted age to younger donors with T1D, which may indicate microbiome perturbations associated with this disease. Although these perturbations may be attributed to a specific diet and medications, we hypothesize that diabetes might also accelerate the aging process via a gut microbiome-associated mechanism.

Although the aging clocks\' primary purpose is to measure the passage of time in biological systems, they can also be used to broaden our knowledge of the fundamental aging process. Using ALE, which explores the model\'s responses to minute changes in feature values, we identified gut prevalent microbes that are associated with aging. It should be noted that, although ALE is a method of feature importance analysis that can be applied to all ML algorithms, its results are not universal and depend both on the dataset structure and the specific model implementation.

Although keystone members of the gut community such as *Bacteroides*, *Eubacterium*, *Bifidobacterium* are shown to have the greatest effect on age prediction, some unexpected opportunistic and environmental bacteria also have an effect. For example, pathogenic *Campylobacter jejuni* abundance is associated with increased predicted age in the DNN model.

We also managed to show that many bacteria display a regular, monotonic effect on age prediction ([Figure S4](#mmc1){ref-type="supplementary-material"}). More specifically, we show that most microbes either increase (seno-positive) or decrease (seno-negative) the estimated age. Meanwhile, microbes that are not consistently associated with changes in the predicted age occur only occasionally ([Figure 4](#fig4){ref-type="fig"}). However, a microbe\'s seno-status does not correspond to its beneficial or harmful function in the gut. Moreover, dataset structure can alter both the amplitude and the direction of the effect, which means that ALEs should not be viewed as a tool for precise quantification. Nonetheless, ALEs can be used to provide a first glimpse into the prediction process of a model and derive hypotheses regarding of the nature underlying the observed regularities.

Among the 41 most important features for the DNN model ([Figure 4](#fig4){ref-type="fig"}) there were nine species belonging to the *Bacteroides/Parabacteroides* group. This reflects the high importance of the group for the gut community: their vast and frequently unique polysaccharide degrading abilities provide other members of the biota with otherwise unattainable sources of energy. However, only four of these species are seno-negative, which illustrates *Bacteroides* ambiguity regarding host-microbe interactions. For example, it contains highly virulent *B*. *fragilis*, which has the capacity to produce enterotoxins and cause life-threatening bacterial infections ([@bib28]). *B*. *thetaiotaomicron* and *B*. *ovatus* have also been associated with inflammatory gut conditions, whereas *B*. *dorei* might be related to occurrence of T1D in children ([@bib10], [@bib25], [@bib26]). Meanwhile, various *Bacteroides* species contribute to the development of intestinal immune system, suppress pathogen growth, and form supporting trophic relations with beneficial bacteria ([@bib26], [@bib28]). These circumstances make interpreting *Bacteroides* involvement in the aging process practically impossible. However, the over-representation of *Bacteroides* among the most important features indicates the need to more closely study these microbes within the aging context.

Unlike the ambiguous *Bacteroides*, *Akkermansia muciniphila*---with the second largest effect amplitude---is commonly considered an indicator of a healthy gut community that is involved in regulating obesity, fat, and glucose metabolism, as well as regulating inflammation and mucin production ([@bib20]). Some propose *A*. *muciniphila* as a new type of probiotic ([@bib30]). Interestingly, centenarian gut communities have a significantly higher abundance of *A*. *muciniphila* than other age groups, which makes it a likely candidate for a healthy aging biomarker ([@bib5]). Its high effect amplitude and seno-negative status, revealed by this study, indicate that it has an important role in intestinal aging. However, our collection of taxonomic profiles is scarce in old individuals and contains only one sample with the maximum age of 90 years. Further investigation into the role of *A*. *muciniphila* in aging should include a larger proportion of elderly people and centenarians.

*Bifidobacterium* genus is represented within the top features by three seno-negative species and one seno-positive. Generally, the seno-negative status of this genus is in line with previous findings, according to which *Bifidobacterium* tend to decrease with aging. Interestingly, the only seno-positive *Bifidobacterium bifidum* is mostly abundant in the elderly and centenarians. Thus, our findings further support that *Bifidobacterium* is directly involved into the aging process. *Bifidobacterium* probiotics convey multiple benefits to the host such as the ability to reduce inflammation in irritable bowel syndrome and prevent anxiety via the gut-brain axis ([@bib3]). We hypothesize that *Bifidobacterium* might also possess certain geroprotective properties and should be studied in the context of biogerontology.

Another notable cluster in the ALEs top features are six species with documented butyrate-producing abilities (*Eubacterium rectale*, *E*. *eligens*, *E*. *hallii*, *Clostridium bolteae*, *Roseburia hominis*, *Faecalibacterium prausnitzii*) ([@bib11]). Butyrate is an essential compound that regulates the gut immune system and colon cancer apoptosis, as well as provides nutrition to colonocytes. It also affects gut-brain axis and possibly autism development. Meanwhile, a decrease in butyrate producers is characteristic of various dysbiotic states ([@bib22], [@bib24]). Our results indicate that butyrate producers, akin to *A*. *muciniphila* or *Bifidobacterium*, can be an aging-related group and affect, or be affected by, the aging processes. Existing data show that butyrate producers do not consistently decrease in abundance with age, as we would expect from a collection of seno-negative species ([@bib6]). Although this may be attributed to sample differences, we would like to emphasize that a bacterium\'s seno-status should always be discussed while keeping in mind that it is determined by the performance of a DNN model that may depend on nonlinear patterns.

The presence of various bacteria that are poorly described within the human gut community context, namely, *Shigella* sp. PAMC 28760, *Gordonibacter urolithinfaciens*, *Streptococcus salivarius*, *Ornithobacterium rhinotracheale*, *Coriobacteriaceae bacterium* 68-1-3, *Streptococcus parasanguinis*, *Acidaminococcus fermentans*, *Streptococcus equinus*, *Chryseobacterium gallinarum*, *Lactobacillus amylophilus*, *Clostridium saccharolyticum*, among the above described features could be attributed to batch effects. However, there is a chance that these understudied taxa can still convey useful information regarding intestinal aging. To decide between these alternatives, the ALEs should be computed on an independent dataset of magnitude comparable with its training set while accounting for various meta variables.

The present finding shows that microbiome profiles can be used to predict the age of healthy individuals with relatively good accuracy. Moreover, patients with T1D exhibit age acceleration according to the microbiome clock. Further validation of this aging biomarker can lead to a valuable addition to the already existing aging clocks, e.g., epigenetic, blood biochemistry, and cell count clocks.

Hypothetical applications of microbiomic clocks may include "intestinal rejuvenation" with dietary interventions. This would require the ability to model microflora composition changes in response to such interventions. Previous studies have shown that microbiome can be manipulated by diets to a certain degree ([@bib9]). But provided that microbiome itself is a major factor defining the outcome of dietary interventions, creating such a model demands a deeper understanding of gut community dynamics and metabolism before intestinal rejuvenation becomes a possibility ([@bib29]).

Limitations of the Study {#sec3.1}
------------------------

This study describes an early attempt to build an aging clock using microbiomic data from adult donors obtained elsewhere. Child microbiota profiles were not used during training, since child microbiota is expected to have significantly different dynamics and balancing the age distribution using child microbiota studies is particularly difficult. We tried predicting child intestinal age using the reported models, but they failed to perform better than baseline in this setting.

It should be noted that no normalization techniques were employed after obtaining the taxonomic profiles. Future work should be directed toward profile normalization to make the performance of such models more consistent across various datasets. However, considering how diverse human gut community is, the development of such normalization techniques poses a serious challenge in itself.

Further development of this work may include constructing an aging clock using genes or functional-level features. However, this direction requires experimentation with feature reduction methods, since the amount of genetic information contained within gut communities is overwhelming for the available sample sizes. The detected number of microbial species in this project already was too big for efficient training, and filtering out the minor species was used to bring down the number of dimensions. Such methods used in the genetic setting may cause multiple artifacts, and more sophisticated approaches are suggested. One of the promising approaches relies on Co-Abundance Group (CAG) calculation, as described in [@bib18]).

Another valuable extension to this project would be observing numerous pathologies through the lens of microbiome aging. Multiple biological processes are considered major drivers of aging, but gut microbiome\'s involvement in this process is still vaguely understood. Approaches such as upgrading the DNN architecture to have two output nodes (separate for age and disease) or predicting the health status using the latent representation obtained from an aging clock DNN may prove to be useful for this task.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests should be directed to and will be fulfilled by the Lead Contact Alex Zhavoronkov (<alex@insilico.com>).

### Data and Code Availability {#sec3.2.2}

All data used in this article come from publicly available sources. Metagenomic studies\' identifiers in ENA: [ERP002061](https://www.ebi.ac.uk/ena/data/view/PRJEB1220){#intref0035}, [ERP008729](https://www.ebi.ac.uk/ena/data/view/PRJEB7774){#intref0040}, [SRP002163](https://www.ebi.ac.uk/ena/data/view/PRJNA48479){#intref0045}, [ERP004605](https://www.ebi.ac.uk/ena/data/view/PRJEB5224){#intref0050}, [ERP003612](https://www.ebi.ac.uk/ena/data/view/PRJEB4336){#intref0055}, [ERP002469](https://www.ebi.ac.uk/ena/data/view/PRJEB1786){#intref0060}, [ERP019502](https://www.ebi.ac.uk/ena/data/view/PRJEB17632){#intref0065}, [SRP008047](https://www.ebi.ac.uk/ena/data/view/PRJNA422434){#intref0070}, [ERP009422](https://www.ebi.ac.uk/ena/data/view/PRJEB8347){#intref0075}, [ERP005534](https://www.ebi.ac.uk/ena/data/view/PRJEB6070){#intref0080}, [PRJEB2054](https://www.ebi.ac.uk/ena/data/view/PRJEB2054){#intref0085}, [PRJNA375935](https://www.ebi.ac.uk/ena/data/view/PRJNA375935){#intref0090}, [PRJNA289586.](https://www.ebi.ac.uk/ena/data/view/PRJNA289586){#intref0095}Only healthy individuals with age metadata available have been included in this study. These studies contain healthy individuals from Austria, China, Denmark, France, Germany, Kazakhstan, Spain, Sweden, and USA aged 20--90 years. For more details on data selection and preparation see [Supplemental Information](#appsec1){ref-type="fn"}. ENA identifiers of the runs used are specified in [Tables S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, [S4](#mmc5){ref-type="supplementary-material"}, and [S5](#mmc6){ref-type="supplementary-material"}.

The models are available at aging.ai in the Floro\'clock section.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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